Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/8/24 → 1/8/26 |
Funding
- WuXi Clinical Development Incorporated: $56,432.00
Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with aSAH
- Hatton, Kevin (PI)
- Cook, Aaron (CoI)
- Dornbos, David (CoI)